FDA Approves Generic HIV Prevention Shot to Boost Global Access
The FDA has approved a generic version of the HIV prevention drug lenacapavir, with an Indian manufacturer pledging to sell it for $40 annually in low- and middle-income countries.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
The story so far
2 publishers have covered this in 2 articles since 2 Nov 2026. Latest News from Science Magazine published first, on 2 November at 05:25 UTC; STAT followed 10h 48m later. The most recent article, from STAT, appeared on 2 November at 16:13 UTC.
Outlets reporting it: Latest News from Science Magazine (major outlet), STAT.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- FDA
- Science Magazine